| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |